Posts Tagged: "patent docs"

Top Patent Blogs for 2018

This is an update for the Top Patent Blogs post that I published back in 2011… In preparing for this Top Patent Blogs post, I reached out to the writers (patent attorneys and patent professor) from the Top Patent Blogs post and asked them a few questions about why they maintain their blogs. Not all responded but from those that did, I got a sense that their blogs are more than just another means of attracting new business. For example, a few use blogging as a reason for reading cases and briefing them to keep up with the current state of patent law. The reasons varied far and wide. To summarize or to get to the essence of their differentiation, I asked them how they felt their blog was different from the others on the list. For their answers, see the Comment by Blog Manager column below in the ranking list.

James Yang

February 8, 2018

The Increasingly Important Roles of Bloggers in Post Grant Proceedings

Both petitioners’ and patent owners’ reliance on blog articles in the course of post grant proceedings has been approximately equal. However, the manner in which the blog articles were used did vary widely based on the litigator’s position during the proceeding. For petitioners, blog articles were most often cited to construe the claims (Apotex Inc. v. Amgen Inc., IPR2016-01542, Paper 2, p.69), were introduced as previous publications of an expert witness in order to help prove their qualifications (Samsung Electronics Co., v. Papst Licensing, IPR2016-01733, Ex. 1014, p. 99), or were used to bolster the credentials of one or more of the representing attorneys (Google, Inc. et al v. Smartflash, CBM2015-00132, Paper 17, p. 2). For patent owners, blog articles were most often referenced to provide support to summarize and clarify certain legal standards such as claim construction standards (Uniloc USA, Inc. et al v. Allscripts Healthcare Solutions, Inc., IPR2015-01615, Paper 12, p. 8), to clarify legislative history and identify Congressional intent (Coalition for Affordable Drugs VII v. Pozen, IPR2015-01241, Paper 13, p. 47), and to rebut the petitioner’s expert testimony by attacking the expert’s credibility (Coalition for Affordable Drugs VII v. Pharmacyclics, IPR2015-01076, Paper 20, p. 13).

Timothy J. Maier

September 25, 2016

News & Notes for September 2013

Clouding IP Faces Inter Partes Review at the USPTO. ***** Goodlatte’s Second “Discussion Draft” of Patent Reform Legislation. ***** IPO White Paper Calls for Update to Patent Examination System. ***** The After Final Consideration Pilot 2.0 (AFCP 2.0), which had been scheduled to expire on September 30, 2013, has been extended through December 14, 2013. ***** Patent Litigator Becomes Managing Partner at Kilpatrick Townsend & Stockton. ***** The requirement for consonance applies to both the patent challenged for double patenting (i.e., the challenged patent) and the patent being used as a reference against the challenged patent (i.e., the reference patent).

Gene Quinn

September 27, 2013

Confessions of an Otherwise Respectable Blogger

Earlier today Kevin Noonan of Patent Docs posted an article titled Falsehoods, Distortions Lies in the Gene Patenting Debate. In the article’s first paragraph Noonan explains that ever since the filing of a complaint by the ACLU challenging the propriety of certain gene patents owned by Myriad Genetics, the debate regarding gene patents has gone mainstream. He wrote: Thus, there…

Gene Quinn

June 16, 2009